Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cariprazine hydrochloride'

Search results for: 'cariprazine hydrochloride'

Items 241-250 of 626

Page
per page
  1. MPEP Hydrochloride
    A3633 MPEP Hydrochloride
    Target: Glutamate (Metabotropic) Group I Receptors
    Summary: MGlu5 receptor antagonist
      Soluble in DMSO
  2. Flavoxate hydrochloride
    B3433 Flavoxate hydrochloride
    Summary: muscarinic AChR antagonist
      ≥4.28 mg/mL
  3. Memantine hydrochloride
    B3308 Memantine hydrochloride
    Summary: NMDA receptor antagonist
      ≥21.62 mg/mL
  4. Cevimeline hydrochloride hemihydrate
    A3300 Cevimeline hydrochloride hemihydrate
    Summary: Agonist of muscarinic receptor (M1/M3)
      Soluble in DMSO
  5. Cytarabine hydrochloride
    B1100 Cytarabine hydrochloride
    Summary: DNA synthsis inhibitor
      insoluble in EtOH; ≥14.2 mg/mL
  6. GNE-617 hydrochloride
    B1309 GNE-617 hydrochloride
    Target: Nampt
    Summary: NAMPT inhibitor, potent and competitive
      Soluble in DMSO
  7. MI-2 (hydrochloride)
    C3326 MI-2 (hydrochloride)
    Summary: menin-MLL interaction inhibitor
      ≤30 mg/mL
  8. SR 1555 (hydrochloride)
    C3485 SR 1555 (hydrochloride)
    Summary: inverse agonist of RORγ
      ≤1.6 mg/mL
  9. StemRegenin 1 (hydrochloride)
    C3551 StemRegenin 1 (hydrochloride)
    Summary: aryl hydrocarbon receptor signaling antagonist
      ≤5 mg/mL
  10. L-Histidinol (hydrochloride)
    C3777 L-Histidinol (hydrochloride)
    Summary: intermediate in the biosynthesis of the amino acid L-histidine
      ≤5 mg/mL

Items 241-250 of 626

Page
per page
Shop By
Shopping Options
Category
  1. Signaling Pathways 526item
  2. Natural Products 14item
  3. Amino Acids & Building Blocks 1 item
  4. Screening Library 33item
  5. Probes & Dyes 2item
  6. Protein & Immunology 2item
  7. Lab Reagents 15item
Specificity
  1. Selective 38item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 2item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 2item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 1 item
  4. PI3K 1 item
  5. Raf 1 item
  6. Aurora Kinases 1 item
  7. EZH2 1 item
  8. mTOR 1 item
  9. Thymidine Phosphorylases 1 item
  10. GSK-3 1 item
  11. VEGFR 1 item
  12. PDGFR 1 item
  13. c-Kit 1 item
  14. Phosphodiesterases (PDEs) 2item
  15. p38 1 item
  16. GABAB Receptors 1 item
  17. Sir2-like Family Deacetylases (Sirtuins) 1 item
  18. Aminopeptidases 1 item
  19. EGFR 2item
  20. FAK 1 item
  21. Syk 1 item
  22. DNA-PK 1 item
  23. HSP90 1 item
  24. AMPK 1 item
  25. Gutathione S-transferase 1 item
  26. Topoisomerases 1 item
  27. Serine Proteases 1 item
  28. Ca2 /calmodulin-dependent protein kinases (CaMKs) 2item
  29. Pyk2 1 item
  30. 5-HT2 Receptors 2item
  31. S1P receptors 1 item
  32. ALK 1 item
  33. Myosin light chain kinases (MLCKs) 1 item
  34. 5-HT3 Receptors 2item
  35. Angiotensin-Converting Enzymes (ACEs) 1 item
  36. Squalene epoxidases 3item
  37. Nampt 1 item
  38. Glutamate (Metabotropic) Group I Receptors 1 item
  39. Urokinases 1 item
  40. Histamine H1 Receptors 1 item
  41. Sigma Receptors 1 item
  42. Apoptosis Inducers 1 item
  43. AChE 1 item
  44. Inward Rectifier Potassium (Kir) Channels 1 item
  45. c-RET 1 item
  46. guanylyl cyclase 1 item
  47. dopamine receptor 1 item
  48. 5-HT1 Receptor 2item
  49. 5-HT2 Receptor 1 item
  50. NMPRTase 1 item
  51. IKK 1 item
  52. Antibiotic 1 item
  53. Calmodulins 1 item
  54. Calcium-Sensing Receptors (CaSRs) 2item
  55. PAR receptor 1 item
  56. TRPC channel 1 item
  57. GABAA receptor 1 item
  58. CRF1 Receptors 1 item
Reported Experiments
  1. Animal Experiments 61item
  2. Cell Experiments 58item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Bacterial Infectios 1 item
  3. Bladder Cancer 2item
  4. Breast Cancer 3item
  5. Cancer 19item
  6. Chronic Lymphocytic Leukemia 1 item
  7. Colon Cancer 3item
  8. Colorectal Cancer 2item
  9. Erectile Dysfunction 1 item
  10. Glioblastoma 2item
  11. Glioma 2item
  12. Hepatocellular Carcinoma 1 item
  13. Inflammatory Diseases 1 item
  14. Leukemia 1 item
  15. Lung Cancer 3item
  16. Multidrug Resistance Studies 1 item
  17. Multiple Myeloma 2item
  18. Narcolepsy 1 item
  19. Non-small Cell Lung Cancer 1 item
  20. Pancreatic Cancer 2item
  21. Prostate Cancer 3item
  22. Schizophrenia 1 item
  23. Type 2 Diabetes 1 item